Scott M Rocklage's Net Worth
Estimate Recalculated Jun 18, 2025 08:33PM EST
Who is Scott M Rocklage
Scott M Rocklage has an estimated net worth of $1.36 Million. This is based on reported shares across multiple companies, which include Skye Bioscience, Inc., Relypsa Inc, Crinetics Pharmaceuticals, Inc., Entrada Therapeutics, Inc., Pear Therapeutics, Inc., Pulmatrix, Inc., IDEAYA Biosciences, Inc., Rallybio Corp, ARVINAS INC., IMPEL NEUROPHARMA INC, Cidara Therapeutics, Inc., VIVEVE MEDICAL, INC., scPharmaceuticals Inc., Cabaletta Bio, Inc., Akouos, Inc., Homology Medicines, Inc., Aprea Therapeutics, Inc., Audentes Therapeutics, Inc., EPIRUS Biopharmaceuticals, Inc., PHASERX, INC., CUBIST PHARMACEUTICALS INC, and Achaogen Inc.
SEC CIK
Scott M Rocklage's CIK is 0001219014
Past Insider Trading and Trends
2004 was Scott M Rocklage's most active year for acquiring shares with 5 total transactions. Scott M Rocklage's most active month to acquire stocks was the month of May. 2004 was Scott M Rocklage's most active year for disposing of shares, totalling 57 transactions. Scott M Rocklage's most active month to dispose stocks was the month of February. 2004 saw Scott M Rocklage paying a total of $184,077.73 for 97,378 shares, this is the most they've acquired in one year. In 2004 Scott M Rocklage cashed out on 181,545 shares for a total of $1,233,488.95, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
